Literature DB >> 23547854

Pregabalin abuse after past substance-seeking behavior.

Georgios Papazisis1, Georgios Garyfallos, Chrysanthi Sardeli, Dimitrios Kouvelas.   

Abstract

Pregabalin is a prescription drug, structurally related to the neurotransmitter GABA. Following the rapidly increasing use of pregabalin, data signaling its abuse liability have been published recently. We report a case of a 19-year-old man with a history of cannabis and alcohol-seeking behavior that showed similar drug-seeking behavior with pregabalin. This report highlights the potential for abuse of pregabalin in patients with a history of substance-seeking behavior. Considering that the drug has recently been proposed as a treatment for alcohol- and benzodiazepine-dependence a better clarification of its abuse potential is essential.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23547854     DOI: 10.5414/CP201881

Source DB:  PubMed          Journal:  Int J Clin Pharmacol Ther        ISSN: 0946-1965            Impact factor:   1.366


  7 in total

Review 1.  Abuse Potential of Pregabalin: A Systematic Review.

Authors:  Ole Schjerning; Mary Rosenzweig; Anton Pottegård; Per Damkier; Jimmi Nielsen
Journal:  CNS Drugs       Date:  2016-01       Impact factor: 5.749

Review 2.  Abuse and Misuse of Pregabalin and Gabapentin.

Authors:  Kirk E Evoy; Megan D Morrison; Stephen R Saklad
Journal:  Drugs       Date:  2017-03       Impact factor: 9.546

3.  A Decade of Gabapentinoid Misuse: An Analysis of the European Medicines Agency's 'Suspected Adverse Drug Reactions' Database.

Authors:  Stefania Chiappini; Fabrizio Schifano
Journal:  CNS Drugs       Date:  2016-07       Impact factor: 5.749

Review 4.  Pharmacotherapy for anxiety and comorbid alcohol use disorders.

Authors:  Jonathan C Ipser; Don Wilson; Taiwo O Akindipe; Carli Sager; Dan J Stein
Journal:  Cochrane Database Syst Rev       Date:  2015-01-20

Review 5.  Pregabalin for the Treatment of Drug and Alcohol Withdrawal Symptoms: A Comprehensive Review.

Authors:  Rainer Freynhagen; Miroslav Backonja; Stephan Schug; Gavin Lyndon; Bruce Parsons; Stephen Watt; Regina Behar
Journal:  CNS Drugs       Date:  2016-12       Impact factor: 5.749

6.  Assessment of the Safety Signal for the Abuse Potential of Pregabalin and Gabapentin Using the FAERS Database and Big Data Search Analytics.

Authors:  Georgios Papazisis; Dimitrios Spachos; Spyridon Siafis; Niki Pandria; Eleni Deligianni; Ioannis Tsakiridis; Antonios Goulas
Journal:  Front Psychiatry       Date:  2021-05-20       Impact factor: 4.157

7.  Pregabalin Misuse and Abuse in Jordan: a Qualitative Study of User Experiences.

Authors:  Amneh Al-Husseini; Mayyada Wazaify; Marie Claire Van Hout
Journal:  Int J Ment Health Addict       Date:  2017-09-15       Impact factor: 3.836

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.